2024: The Year in Cardiovascular Disease - The Year of Lipoprotein(a) – Research Advances and New Findings.

2024: The Year in Cardiovascular Disease - The Year of Lipoprotein(a) – Research Advances and New Findings.

Elevated plasma lipoprotein(a) [Lp(a)] levels, which occur in as many as 1.5 billion people worldwide, are an independent and causal risk factor for atherosclerotic cardiovascular disease and calcific aortic valve disease. Unlike low-density lipoprotein cholesterol, Lp(a) levels are approximately 70...

Full description

Saved in:
Bibliographic Details
Main Authors: Bożena Sosnowska, Peter P. Toth, Alexander C Razavi, Alan T Remaley, Roger S Blumenthal, Maciej Banach
Format: Article
Language:English
Published: Termedia Publishing House 2025-02-01
Series:Archives of Medical Science
Subjects:
aortic valve calcification
atherosclerosis
cardiovascular disease
lipoprotein(a)
apo(a) isoforms
rna therapeutics
outcomes
variability
Online Access:https://www.archivesofmedicalscience.com/2024-The-Year-in-Cardiovascular-Disease-The-Year-of-Lipoprotein-a-Research-Advances,202213,0,2.html
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.archivesofmedicalscience.com/2024-The-Year-in-Cardiovascular-Disease-The-Year-of-Lipoprotein-a-Research-Advances,202213,0,2.html

Similar Items